A detailed history of Teza Capital Management LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Teza Capital Management LLC holds 22,506 shares of TGTX stock, worth $664,827. This represents 0.06% of its overall portfolio holdings.

Number of Shares
22,506
Holding current value
$664,827
% of portfolio
0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$17.21 - $25.28 $387,328 - $568,951
22,506 New
22,506 $526,000
Q4 2023

Feb 14, 2024

BUY
$6.68 - $18.81 $150,934 - $425,011
22,595 New
22,595 $385,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.29B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Teza Capital Management LLC Portfolio

Follow Teza Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Teza Capital Management LLC with notifications on news.